HAEMATOLOGICAL CANCER: GUIDANCE

Improving outcomes in haematological cancers: cancer guidance

Background

NICE issued guidance on the organisation of healthcare for people with haematological cancers (cancers of blood cells). It recommended which healthcare professionals should be involved in treatment and care, and the facilities, such as hospitals, best suited to provide that healthcare. CRD was commissioned to undertake the systematic review work that provided the evidence to support the recommendations in the guidance.

Findings

The key recommendations in the guidance were that people should be treated by a multidisciplinary team that includes a clinical nurse specialist and a palliative care specialist, and that each diagnosis of haematological cancer should be reviewed by experts. People with neck lumps should have rapid access to diagnostic services; complex chemotherapy for acute leukaemia should be carried out by specialist teams and high-dose therapy and transplantation should be carried out in accredited centres.

Conducted by: CRD in collaboration with Cancer Research UK Oncology Unit, Cancer Sciences Division, University of Southampton School of Medicine; Health Services Research Unit, Community Clinical Sciences Research Division, University of Southampton School of Medicine; Barts and the London NHS Trust, Queen Mary University of London Medical and Dental School.

Related guidance

Commissioned to inform NICE cancer service guidance: Improving outcomes in haematological cancers: the manual. London: National Institute for Clinical Excellence; 2003

Improving outcomes in haematological cancers: the research evidence. London: National Institute for Clinical Excellence; 2003.(Guidance for Commissioning Cancer Services)

Funding

Commissioned by NICE (Inherited project)